Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 1, 2012, Pages 141-151

  Walter, Jan ^a   Handel, Linn L ^a   Brodhun, Michael ^b   Van Rossum, Denise ^c   Hanisch, Uwe Karsten ^c   Liebmann, Lutz ^d   Heppner, Frank ^e   Goldbrunner, Roland ^f   Koch, Arend ^e   Kuhn, Susanne A ^a,g  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Brain metastases; Coagulation factor receptors; Coagulation factors; Protease activated receptors

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; D DIMER; FIBRINOGEN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

ADULT; AGED; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, PROTEINASE-ACTIVATED; UP-REGULATION; YOUNG ADULT;

EID: 84857058594     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1078-x     Document Type: Article

References (51)

1. Balzarotti M, Fontana F, Marras C, Boiardi A, Croci D, Ciusani D, Salmaggi A (2006) In vitro study of low molecular weight heparin eVect on cell growth and cell invasion in primary cell cultures of high-grade gliomas. Oncol Res 16(5):245-250 (Pubitemid 46211728)
2. Bartha K, Domotor E, Lanza F et al (2000) IdentiWcation of thrombin receptors in rat brain capillary endothelial cells. J Cereb Blood Flow Metab 20:175-182 (Pubitemid 30019843)
3. Berger MS, Prados MD (2005) Textbook of neuro-oncology. Elsevier Saunders, Philadelphia 3-475
4. Burger P, Scheithauer BW, Vogel FS (2002) Surgical pathology of the nervous system and its coverings. Churchill Livingstone, New York, pp 49-112
5. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264
6. Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800-1814 (Pubitemid 41716567)
7. Darmoul D, Gratio V, Devaud H et al (2004) Activation of proteaseactivated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2:514-522 (Pubitemid 39281733)
8. Deitcher S (2003) Cancer-related deep venous thrombosis: clinical importance, treatment challenges and management strategies. Semin Thromb Hemost 29(3):247-258 (Pubitemid 36776187)
9. Donati MB, Falanga A (2001) Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 106:18-24 (Pubitemid 32830512)
10. Donovan FM, Pike CJ, Cotman CW et al (1997) Thrombin induces apoptosis in cultures neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316-5326
11. Duenisch P, Reichart R, Mueller U, Brodhun M, Bjerkvig R, Romeike B, Walter J, Herbold C, Regenbrecht CR, KalV R, Kuhn SA (2010) Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases. J Cancer Res Clin Oncol. 2010 May 4. doi:10.1007/s00432- 010-0888-6
12. Fadul CE, Zacharski LR (2005) Coagulation biology in glioma pathogenesis: a missing link? J Thromb Haemost 3(9):1915-1916 (Pubitemid 43086044)
13. Furman MI, Lui L, Benoit SE et al (1998) The cleaved peptide of the thrombin receptor is a strong platelet agonist. Proc Natl Acad Sci USA 95:3082-3087 (Pubitemid 28135858)
14. Giagounidis A, Germing U, Haas R (2001) Zytostatische Therapie: EinXüsse auf das Hämostasesystem. Hämastaseologie 21:1-4 (Pubitemid 32202372)
15. Goldschmidt N, Linetsky E, Shalom E et al (2003) High incidence of thromboembolism in patients with central nervous system lymphoma. Cancer 98:1239-1242 (Pubitemid 37099909)
16. Gouin-Thibault I, Achkar A, Samama MM (2001) The thrombophilic state in cancer patients. Acta Haematol 106:33-42 (Pubitemid 32830514)
17. Grabham P, Cunningham DD (1995) Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J Neurochem 64:583-591
18. Guan M, Jin J, Su B, Liu W, Lu Y (2002) Tissue factor expression and angiogenesis in human glioma. Clin Biochem 35(4):321-325 (Pubitemid 34804904)
19. Hach-Wunderle V, Hach W (1999) Das Trousseau-Syndrom. Gefässchirurgie 4:50-54
20. Hollenberg MD, Compton SJ (2002) International union of pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54:203-217 (Pubitemid 34575710)
21. Hua Y, Tang L, Keep RF et al (2005) The role of thrombin in gliomas. J Thromb Haemost 3:1917-1923 (Pubitemid 43086045)
22. Kaufmann R, Patt S, Schafberg H et al (1998) Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells. Neuroreport 9:709-712 (Pubitemid 28131290)
23. Korte W (2000) Changes of coagulation and Wbrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures. Clin Chem Lab Med 38:679-692
24. Kwaan HC, Gordon LI (2001) Thrombotic microangiopathy in the cancer patient. Acta Haematol 106:52-56 (Pubitemid 32830516)
25. Levine MN, Lee AYY (2001) Treatment of venous thrombosis in the cancer patient. Acta Haematol 106:81-87 (Pubitemid 32830520)
26. Maiolo A, Tua A, Grignani G (2002) Hemostasis and cancer: tumor cells induce the expression of tissue factor-like procoagulant activity on endothelial cells. Haematologica 87(6):624-628 (Pubitemid 34640645)
27. Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 89:640-646 (Pubitemid 30640111)
28. Möller T, Hanisch UK, Ransom BR (2000) Thrombin-induced activation of cultured rodent microglia. J Neurochem 75:1539-1547
29. Mousa SA (2006) Role of current and emerging antithrombotics in thrombosis and cancer. Drugs Today 42:331-350 (Pubitemid 43980718)
30. Nierodzik MLR, Bain RM, Liu LX et al (1996) Presence of the seven transmembrane thrombin receptor oh human tumour cells: eVect of activation of tumour adhesion to platelets and tumour tyrosine phosphorylation. Br J Haematol 92:452-457 (Pubitemid 26042943)
31. Nierodzik ML, Chen K, Takeshita K et al (1998) Protease-activated receptors 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92:3694-3700 (Pubitemid 28525196)
32. Niewenhuizen W (1995) Biochemistry and measurement of Wbrinogen. Eur Heart J 16(Suppl A):6-10
33. Nigel W, Bunnett PD (2006) Protease-activated receptors: how proteases signal to cells to cause inXammation and pain. Semin Thromb Hemost 32(suppl):39-48
34. Ornstein DL, Meehan KR, Zacharski LR (2002) The coagulation system as a target for the treatment of human gliomas. Sem Thromb Hemost 28:19-27 (Pubitemid 34201777)
35. Piccioli A, Prandoni P (2001) Venous thromboembolism as Wrst manifestation of cancer. Acta Haematol 106:13-17 (Pubitemid 32830511)
36. Prandoni P (2010) The treatment of venous thromboembolism in patients with cancer. Intern Emerg Med 5(Suppl 1):S27-30
37. Pruemer J (2005) Prevalence, causes and impact of cancer-associated thrombosis. Am J Health Syst Pharm 62:4-6
38. Renesto P, Si-Tahar M, Moniatte M et al (1997) SpeciWc inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the amino terminal domain of the thrombin receptor. Blood 89:1944-1953 (Pubitemid 27132109)
39. Sawaya R, Glas-Greenwalt P (1992) Postoperative venous thromboembolism and brain tumors: part II. Hemostatic proWle. J Neuro- Oncol 14:127-134
40. Sawaya R, Ligon BL (1994) Thromboembolic complications associated with brain tumors. J Neuroonc 22:173-181
41. Schmidt F, Faul C, Dichgans J et al (2002) Low molecular weight heparin for deep vein thrombosis in glioma patients. J Neurol 249:1409-1412 (Pubitemid 35217664)
42. Suo Z, Wu M, Ameenuddin S et al (2002) Participation of proteaseactivated receptor-1 in thrombin-induced microglial activation. J Neurochem 80:655-666 (Pubitemid 34809974)
43. Thodiyil PA, Walsh DC, Kakkar Ak (2001) Thromboprophylaxis in the cancer patient. Acta Haematol 106:73-80 (Pubitemid 32830519)
44. Thomas L (2005) Laboratory and diagnosis [Labor und Diagnose, German] 6th edn, Frankfurt/Main.TH-Books
45. Trikha M, Nakada MT (2002) Platelets and cancer: implications for antiangiogenic therapy. Sem Thromb Hem 28:39-44 (Pubitemid 34194871)
46. Trousseau A (1865) Phlegmasia alba dolens: Clinique mèdicale De l'Hôtel-Dieu de Paris, 2nd edn. JB Baillière et Fils, Paris, vol 3, pp 654-712
47. Van Meir EG, Brat DJ (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397-405 (Pubitemid 41656467)
48. Wells PS, Anderson DR, Rodger M (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein-thrombosis. N Engl J Med 349:1227-1235 (Pubitemid 37152032)
49. Wojtukiewicz MZ, Sierko E, Rak J (2004) Contribution of the hemostatic system to angiogenesis in cancer. Sem Thromb Hem 30:5-20 (Pubitemid 38457297)
50. Yamahata H, Takeshima H, Kuratsu J, Sarker K, Tanioka K, Wakimaru N, Nakata M, Kitajima I, Maruyama I (2002) The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor. Int J Oncol 20(5):921-928
51. Yokota N, Koizume S, Miyagi E, Hirahara F, Nakamura Y, Kikuchi K, Ruf W, Sakuma Y, Tsuchiya E, Miyagi Y (2009) Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. Br J Cancer 101(12):2023-2029